DrugPatentWatch Database Preview
Profile for Canada Patent: 2594764
» See Plans and Pricing
US Patent Family Members and Approved Drugs for Canada Patent: 2594764
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
Start Trial | Jan 20, 2026 | Novo | OZEMPIC | semaglutide |
Start Trial | Jan 20, 2026 | Novo | SAXENDA | liraglutide recombinant |
Start Trial | Jan 20, 2026 | Novo | OZEMPIC | semaglutide |
Start Trial | Jan 20, 2026 | Novo | OZEMPIC | semaglutide |
Start Trial | Jul 26, 2026 | Novo | SAXENDA | liraglutide recombinant |
Start Trial | Jul 20, 2026 | Novo | SAXENDA | liraglutide recombinant |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |